DOCSLIB.ORG

The Potential As New Treatment Agent of Urolithin-A Metabolized from Ellagic Acid by Gut Microbiota in Cancer

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

Special Reviews Juntendo Medical Journal 2021. 67(2),131-139 The Potential as New Treatment Agent of Urolithin-A Metabolized from Ellagic Acid by Gut Microbiota in Cancer TOSHIYUKI OKUMURA＊1) 2) ＊1)Department of Womenʼs Health,Eberhard Karls University of Tuebingen,Land Baden-Württemberg,Germany, ＊2)Department of Obstetrics and Gynecology,Juntendo University Faculty of Medicine,Tokyo,Japan Cancer is the leading cause of death in Japan. Cancer is treated by multidisciplinary therapy such as surgery, chemotherapy,molecular target therapy and radiotherapy. However,almost of advanced cancer relapse after treatment. The relapsed cancer acquires resistance to the therapeutic agents we already used. The prognosis of relapsed cancer is very poor. Therefore,new treatment agents are needed urgently. In recent years metabolites derived from natural foods are focused as new therapeutic agents of cancer diseases. The metabolites are expected to cause less side effect than chemotherapy and have same effect as chemotherapy to cancer. Furthermore therapeutic agents from natural foods are Ellagic acid is metabolite derived from nuts,berries,and pomegranates. Ellagic acid is known to have anticancer effects,due to affecting apoptosis,cell proliferation and cell cycle regulation. Some of metabolites from ellagic acid also have anticancer effect. Urolithins are gut derived bacterial metabolites from ellagic acid. Many articles reported that Urolithin-A has anticancer effect for many cancers. Urolithin-A was reported to regulate p53 protein, caspase 3, caspase 7, AKT, aromatase and PARP in some cancers. Actin polymerization is regulated via Rac1 pathway by Urolithin-A in endometrial cancer. Furthermore, proliferation of many cancer cell lines is suppressed by UA. Safety of UA was investigated by using Rat model. The article suggested Urolithin-A has less genotoxicity compared with cyclophosphamide. Thus,Urolithin-A might be able to have a role as new treatment agent to cancer. Key words: cancer,gut microbiota,ellagic acid,Urolithin-A,new cancer therapeutic agent Cancer growth after adjuvant chemo therapy. However almost of all advanced cancer will be relapsed after The cause of cancer has not yet been clarified. treatment. The prognosis of advanced or relapse However population of cancer patient is increasing cancer is poor still now. The new treatment agent is year by year. It is common that staging of cancer is needed to be identified urgently. divided according to spread of cancer. Treatment plan for cancer is choose depends on progress of Ellagic acid cancer. Almost of all cancers are treated by surgery,chemotherapy,radiotherapy,molecular Recently component purified from natural food is target therapy,or combination of these therapeutic expected to be used as new treatment agent to approaches. These molecular target therapies are cancers. Ellagic acid is known as a metabolite derived used as treatment agent or maintenance agent. from seeds (walnuts,almonds),fruits (persimmons, Maintenance agent is used to suppress tumor berries,peaches,palms,and pomegranate) and Toshiyuki Okumura Department of Obstetrics and Gynecology,Juntendo University Faculty of Medicine 2-1-1 Hongo,Bunkyo-ku,Tokyo 113-8421,Japan TEL: +81-3-3813-3111 E-mail: [email protected] Triannual Meeting of the Juntendo Medical Society“MedicalResearch Update”〔The meeting was originally scheduled to be held on May 16, 2020,but was canceled due to COVID-19 pandemic〕 〔Received July 30, 2020〕〔Accepted Jan. 22,2021〕 Copyright © 2021 The Juntendo Medical Society. This is an open access article distributed under the terms of Creative Commons Attribution Li- cense (CC BY),which permits unrestricted use,distribution,and reproduction in any medium,provided the original source is properly credited. doi: 10.14789/jmj.2021.67.JMJ20-R17 131 Okumura T: The potential as new treatment agent of Urolithin-A metabolized from ellagic acid by gut microbiota in cancer Ellagitannins Seeds（walnuts, almonds）, Fruits（berries, palms, pomegranate, etc.） GM Vegetables Punicalagin Corilagin Vescalagin Urolithin－D Unknown Urolithin－M5 GM DE GM Urolithin－M6 Unknown DE Ellagic acid Urolithin－C Urolithin－E Urolithin－M7 Unknown DE GM：Gut microbiota Urolithin－A DE：Dehydroxylase enzyme CYP：Cytochrome P450 DE CYP enzyme Urolithin－B Figure-1 Metabolite way of seeds,fruits and vegetables to Urolithin-A Some gut microbiotas involved in metabolite way are clarified,but not all. The gut microbiota which produces Urolithin-A from Urolithin-M7 is not found. vegetables. 1) Ellagic acid derived from Ellagitan- on antioxidant function of Ellagic acid to investigate nins (Punicalagin,Corilagin and Vescalagin) 2)(Fig- neuroprotective function of Ellagic acid. The ure-1). Ellagic acid is known to have antioxidant symptom of dementia and brain damage induced by function,anti-inflammatory activity,neuroprotec- streptozotocin was decreased by Ellagic acid in tive function and anticancer effect. Ascorbic acid rats. 12) Motor impairment is improved by Ellagic and α-tocopherol are well known as antioxidant. acid due to reducing neuroinflammatory bio- Indeed,articles shows that Ellagic acid is able to markers (IL-1β and TNF-α) in lesioned rats. On eliminate activation of peroxyl radicals,nitrogen the other hand,the brain is protected against free dioxide,hydroxyl radical and peroxynitrite. 3) 4) radical induced neural damage by Ellagic acid. 13) Intriguingly,Ellagic acid is shown to reduce the Studies have shown that Ellagic acid might be able amount of 8-oxo-2ʼ-deoxyguanosine which is one of to have role as anticancer agent by regulating marker of oxidative DNA damage after DNA carcinogenesis,apoptosis,induced DNA damage damage induced by oxidative stress. 5) 6) Pathophy- due to oxidative stress and angiogenesis in various siological event of inflammation is related to cancers. Ellagic acid increased IL-6 and downregu- oxidative stress. 7) Ellagic acid deactivates AP-1 lated the expression level of pERK1/2,pSTAT3 and and MAPK that are induced by TNF-α and IL-1β. pAkt in PC3 cells which is androgen-independent However,NF- κB is activated by Ellagic acid. 8) 9) prostate cancer cell line. 14) Ellagic acid induced Furthermore,Ellagic acid regulates COX-2 mRNA apoptosis by caspase-3 activation in the transgenic expression by inhibition of ROS production that rat for prostate adenocarcinoma model. Ellagic acid inhibits NF-κB activity. 10) The regulator of COX-2 induced apoptosis by increasing Bax/Bcl-2 ratio expression is NF-κB. 11) The effect of Ellagic acid as and cell cycle related proteins cdk-2,cyclin E,p21 a neuroprotective agent has been investigated by and p27,but not cdk-1 and cyclin D1 in androgen using various assays. Almost of all articles focused dependent prostate cancer cell line,LNCaP. 15) Cell 132 Juntendo Medical Journal 67(2),2021 proliferation of HCT-15 colon adenocarcinoma cells the lactone rings to produce luteic acid. Three was decreased by Ellagic acid. Ellagic acid tetrahydroxy-urolithins,Urolithin-D,Urolithin-M6 decreased cell viability and induced cell cycle arrest and Urolithin-E are produced from Urolithin-M5. in G2/M. Cyclin D1 is decreased by Ellagic acid in Trihydroxy-urolithins,Urolithin-C and Urolithin- HCT-15 cells. Furthermore,Ellagic acid inhibited M7 are then transformed from tetrahydroxy-uroli- the PI3K/Akt pathway in HCT-15 cells. The thins. Trihydroxy-urolithins finally lead to the main expression level of caspase-3, cytochrome C and Bax metabolites,the dihydroxy-urolithin which is were increased by Ellagic acid. 16) Ellagic acid had known as Urolithin-A and the mono-hydroxy antiproliferative effect by inducing cell cycle arrest urolithin that is known as Urolithin-B 23)(Figure-1). in G0/G1 in MCF7 cells,a human breast cancer cell The literature about the bacterial species responsi- line through regulation of TGF-β/Smads signaling ble for urolithin production from ETs,or other pathway. 17) Ellagic acid showed decrease of chemo- EA-derived compounds are deficient. Recently, resistance to cisplatin in A2780CisR,a human Gordonibacter urolithinfaciens (DSM 27213T) and ovarian cancer cell line acquired resistance to G. pamelaeae (DSM 19378T) producing urolithin cisplatin by intermittent treatment with cisplatin were found in human feces. These bacteria for 26 weeks. 18) Ellagic acid inhibited growth of belonged to the family Coriobacteriaceae. 24) 25) human endometrial cancer cell line by decreasing These microbes generated Urolithin-M5,Urolithin- sodium-hydrogen antiporter 1 expression level, M6,and Urolithin-C. However,Urolithin-A and activity of Na+/H+ exchanger,glucose uptake, Urolithin-B were not produced in pure cultures. 24) lactate release and cytosolic pH. 19) HeLa cells, Other bacteria which are needed to produce human cervical cancer cell line was decreased cell Urolithin-A and Urolithin-B from precursor are proliferation by Ellagic acid by downregulation of still unknown. Studies had shown that absorption of Akt/mTOR signaling pathway via increase of Ellagic acid was poor. (Figure-1) However,Uroli- IGFB7. 20) Ellagic acid had a role as anticancer effect thin-A and -B were reported to be distributed in glioblastoma. Ellagic acid decreased cell prolifera- throughout colon,urine,feces,plasma and prostate tion and viability in U118 and U87,human glioblas- tissues following intake of foods or juices enriched toma cell line. Ellagic acid induced cell cycle arrest Ellagic acid. 26) 27) Urolithin-A and -B decreased in S phase in those cell lines. Furthermore,Ellagic endometrial cancer cell proliferation compared with acid showed same effect in glioblastoma xenograft other compounds derived from ellagitannin,antho- model. Ellagic acid inhibited tumor growth by cyanin,sugar,lignan and fiber. 28) Therefore,respon- decreasing MMP-2, MMP-9, Snail, Bcl-2, cdk-2, sibility for the health effect of Ellagic acid have been cdk6 and cyclinD1 and increasing E-cadherin suggested to be Urolithin-A and -B. expression level. Ellagic acid inhibited Notch and Akt signaling pathway. 21) Ellagic acid increased The effect of Urolithin-A apoptosis mediated ROS in B-lymphocytes taken from patients had chronic lymphocytic leukemia by 1.
Recommended publications
  • Pomegranate: Nutraceutical with Promising Benefits on Human Health

    Pomegranate: Nutraceutical with Promising Benefits on Human Health

    Preprints (www.preprints.org) | NOT PEER-REVIEWED | Posted: 8 September 2020 Review Pomegranate: nutraceutical with promising benefits on human health Anna Caruso 1, +, Alexia Barbarossa 2,+, Antonio Tassone 1 , Jessica Ceramella 1, Alessia Carocci 2,*, Alessia Catalano 2,* Giovanna Basile 1, Alessia Fazio 1, Domenico Iacopetta 1, Carlo Franchini 2 and Maria Stefania Sinicropi 1 1 Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, 87036, Arcavacata di Rende (Italy); anna.caruso@unical .it (Ann.C.), [email protected] (A.T.), [email protected] (J.C.), [email protected] (G.B.), [email protected] (A.F.), [email protected] (D.I.), [email protected] (M.S.S.) 2 Department of Pharmacy‐Drug Sciences, University of Bari “Aldo Moro”, 70126, Bari (Italy); [email protected] (A.B.), [email protected] (Al.C.), [email protected] (A.C.), [email protected] (C.F.) + These authors equally contributed to this work. * Correspondence: [email protected] Abstract: The pomegranate, an ancient plant native to Central Asia, cultivated in different geographical areas including the Mediterranean basin and California, consists of flowers, roots, fruits and leaves. Presently, it is utilized not only for the exterior appearance of its fruit but above all, for the nutritional and health characteristics of the various parts composing this last one (carpellary membranes, arils, seeds and bark). The fruit, the pomegranate, is rich in numerous chemical compounds (flavonoids, ellagitannins, proanthocyanidins, mineral salts, vitamins, lipids, organic acids) of high biological and nutraceutical value that make it the object of study for many research groups, particularly in the pharmaceutical sector.
  • Urolithin A, a Gut Metabolite, Improves Insulin Sensitivity Through Augmentation of Mitochondrial Function and Biogenesis

    Urolithin A, a Gut Metabolite, Improves Insulin Sensitivity Through Augmentation of Mitochondrial Function and Biogenesis

    University of Nebraska - Lincoln DigitalCommons@University of Nebraska - Lincoln Nutrition and Health Sciences -- Faculty Publications Nutrition and Health Sciences, Department of 2019 Urolithin A, a Gut Metabolite, Improves Insulin Sensitivity through Augmentation of Mitochondrial Function and Biogenesis Ashley Mulcahy Toney University of Nebraska-Lincoln Rong Fan University of Nebraska-Lincoln Yibo Xian University of Nebraska-Lincoln Virginia Chaidez University of Nebraska-Lincoln, [email protected] Amanda E. Ramer-Tait University of Nebraska-Lincoln, [email protected] FSeeollow next this page and for additional additional works authors at: https:/ /digitalcommons.unl.edu/nutritionfacpub Part of the Analytical, Diagnostic and Therapeutic Techniques and Equipment Commons, Enzymes and Coenzymes Commons, Human and Clinical Nutrition Commons, Molecular, Genetic, and Biochemical Nutrition Commons, and the Other Nutrition Commons Toney, Ashley Mulcahy; Fan, Rong; Xian, Yibo; Chaidez, Virginia; Ramer-Tait, Amanda E.; and Chung, Soonkyu, "Urolithin A, a Gut Metabolite, Improves Insulin Sensitivity through Augmentation of Mitochondrial Function and Biogenesis" (2019). Nutrition and Health Sciences -- Faculty Publications. 238. https://digitalcommons.unl.edu/nutritionfacpub/238 This Article is brought to you for free and open access by the Nutrition and Health Sciences, Department of at DigitalCommons@University of Nebraska - Lincoln. It has been accepted for inclusion in Nutrition and Health Sciences -- Faculty Publications by an authorized administrator of DigitalCommons@University of Nebraska - Lincoln. Authors Ashley Mulcahy Toney, Rong Fan, Yibo Xian, Virginia Chaidez, Amanda E. Ramer-Tait, and Soonkyu Chung This article is available at DigitalCommons@University of Nebraska - Lincoln: https://digitalcommons.unl.edu/ nutritionfacpub/238 Published in Obesity Biology and Integrated Physiology 27 (2019), pp.
  • In Vitro Bioaccessibility, Human Gut Microbiota Metabolites and Hepatoprotective Potential of Chebulic Ellagitannins: a Case of Padma Hepatenr Formulation

    In Vitro Bioaccessibility, Human Gut Microbiota Metabolites and Hepatoprotective Potential of Chebulic Ellagitannins: a Case of Padma Hepatenr Formulation

    Article In Vitro Bioaccessibility, Human Gut Microbiota Metabolites and Hepatoprotective Potential of Chebulic Ellagitannins: A Case of Padma Hepatenr Formulation Daniil N. Olennikov 1,*, Nina I. Kashchenko 1,: and Nadezhda K. Chirikova 2,: Received: 28 August 2015 ; Accepted: 30 September 2015 ; Published: 13 October 2015 1 Laboratory of Medical and Biological Research, Institute of General and Experimental Biology, Siberian Division, Russian Academy of Science, Sakh’yanovoy Street 6, Ulan-Ude 670-047, Russia; [email protected] 2 Department of Biochemistry and Biotechnology, North-Eastern Federal University, 58 Belinsky Street, Yakutsk 677-027, Russian; [email protected] * Correspondence: [email protected]; Tel.: +7-9021-600-627; Fax: +7-3012-434-243 : These authors contributed equally to this work. Abstract: Chebulic ellagitannins (ChET) are plant-derived polyphenols containing chebulic acid subunits, possessing a wide spectrum of biological activities that might contribute to health benefits in humans. The herbal formulation Padma Hepaten containing ChETs as the main phenolics, is used as a hepatoprotective remedy. In the present study, an in vitro dynamic model simulating gastrointestinal digestion, including dialysability, was applied to estimate the bioaccessibility of the main phenolics of Padma Hepaten. Results indicated that phenolic release was mainly achieved during the gastric phase (recovery 59.38%–97.04%), with a slight further release during intestinal digestion. Dialysis experiments showed that dialysable phenolics were 64.11% and 22.93%–26.05% of their native concentrations, respectively, for gallic acid/simple gallate esters and ellagitanins/ellagic acid, in contrast to 20.67% and 28.37%–55.35% for the same groups in the non-dialyzed part of the intestinal media.
  • Concentrations of Blood Serum and Urinal Ellagitannin Metabolites Depend Largely on the Post-Intake Time and Duration of Strawberry Phenolics Ingestion in Rats

    Concentrations of Blood Serum and Urinal Ellagitannin Metabolites Depend Largely on the Post-Intake Time and Duration of Strawberry Phenolics Ingestion in Rats

    Pol. J. Food Nutr. Sci., 2019, Vol. 69, No. 4, pp. 379–386 DOI: 10.31883/pjfns/111866 http://journal.pan.olsztyn.pl Original article Section: Nutritional Research Concentrations of Blood Serum and Urinal Ellagitannin Metabolites Depend Largely on the Post-Intake Time and Duration of Strawberry Phenolics Ingestion in Rats Ewa Żary-Sikorska1*, Monika Kosmala2, Joanna Milala2, Bartosz Fotschki3, Katarzyna Ognik4, Jerzy Juśkiewicz3 1Department of Microbiology and Food Technology, Faculty of Agriculture and Biotechnology University of Science and Technology, Kaliskiego 7, 85–796 Bydgoszcz, Poland 2Institute of Food Technology and Analysis, Łódź University of Technology, Stefanowskiego 4/10, 90–924 Łódź, Poland 3Department of Biological Functions of Food, Institute of Animal Reproduction and Food Research of the Polish Academy of Sciences, Tuwima 10, 10–748 Olsztyn, Poland 4Department of Biochemistry and Toxicology, Faculty of Biology, Animal Sciences and Bioeconomy, University of Life Sciences, Akademicka 13, 20–950 Lublin, Poland Key words: strawberry, ellagitannins, metabolites, urine, serum, rat The different duration of a strawberry phenolic fraction intake and different post-intake time were experimental factors affecting the concentrations of ellagitannin metabolites in the urine and blood serum of rats. For four days, the animals were gavaged once a day as follows: group C (water, days 1–4), group F1–4 (fraction, days 1–4), group F1–3 (fraction, days 1–3; water, day 4), group F1–2 (fraction, days 1, 2; water, days 3, 4), group F3–4 (water, days 1, 2; fraction, days 3, 4), and group F4 (water, days 1–3; and fraction, day 4). The daily dosage of the fraction gavaged to one rat was 20 mg/kg of body weight.
  • Universidade Federal Do Rio De Janeiro Kim Ohanna

    Universidade Federal Do Rio De Janeiro Kim Ohanna

    UNIVERSIDADE FEDERAL DO RIO DE JANEIRO KIM OHANNA PIMENTA INADA EFFECT OF TECHNOLOGICAL PROCESSES ON PHENOLIC COMPOUNDS CONTENTS OF JABUTICABA (MYRCIARIA JABOTICABA) PEEL AND SEED AND INVESTIGATION OF THEIR ELLAGITANNINS METABOLISM IN HUMANS. RIO DE JANEIRO 2018 Kim Ohanna Pimenta Inada EFFECT OF TECHNOLOGICAL PROCESSES ON PHENOLIC COMPOUNDS CONTENTS OF JABUTICABA (MYRCIARIA JABOTICABA) PEEL AND SEED AND INVESTIGATION OF THEIR ELLAGITANNINS METABOLISM IN HUMANS. Tese de Doutorado apresentada ao Programa de Pós-Graduação em Ciências de Alimentos, Universidade Federal do Rio de Janeiro, como requisito parcial à obtenção do título de Doutor em Ciências de Alimentos Orientadores: Profa. Dra. Mariana Costa Monteiro Prof. Dr. Daniel Perrone Moreira RIO DE JANEIRO 2018 DEDICATION À minha família e às pessoas maravilhosas que apareceram na minha vida. ACKNOWLEDGMENTS Primeiramente, gostaria de agradecer a Deus por ter me dado forças para não desistir e por ter colocado na minha vida “pessoas-anjo”, que me ajudaram e me apoiaram até nos momentos em que eu achava que ia dar tudo errado. Aos meus pais Beth e Miti. Eles não mediram esforços para que eu pudesse receber uma boa educação e para que eu fosse feliz. Logo no início da graduação, a situação financeira ficou bem apertada, mas eles continuaram fazendo de tudo para me ajudar. Foram milhares de favores prestados, marmitas e caronas. Meu pai diz que fez anos de curso de inglês e espanhol, porque passou anos acordando cedo no sábado só para me levar no curso que eu fazia no Fundão. Tinha dia que eu saía do curso morta de fome e quando eu entrava no carro, tinha uma marmita com almoço, com direito até a garrafa de suco.
  • Formulation Strategies to Improve Oral Bioavailability of Ellagic Acid

    Formulation Strategies to Improve Oral Bioavailability of Ellagic Acid

    Preprints (www.preprints.org) | NOT PEER-REVIEWED | Posted: 7 April 2020 doi:10.20944/preprints202004.0100.v1 Peer-reviewed version available at Appl. Sci. 2020, 10, 3353; doi:10.3390/app10103353 Review Formulation strategies to improve oral bioavailability of ellagic acid Guendalina Zuccari 1,*, Sara Baldassari 1, Giorgia Ailuno 1, Federica Turrini 1, Silvana Alfei 1, and Gabriele Caviglioli 1 1 Department of Pharmacy, Università di Genova, 16147 Genova, Italy * Correspondence: [email protected]; Tel.: +39 010 3352627 Featured Application: An updated description of pursued approaches for efficiently resolving the low bioavailability issue of ellagic acid. Abstract: Ellagic acid, a polyphenolic compound present in fruits and berries, has recently been object of extensive research for its antioxidant activity, which might be useful for the prevention and treatment of cancer, cardiovascular pathologies, and neurodegenerative disorders. Its protective role justifies numerous attempts to include it in functional food preparations and in dietary supplements not only to limit the unpleasant collateral effects of chemotherapy. However, ellagic acid use as chemopreventive agent has been debated because of its poor bioavailability associated to low solubility, limited permeability, first pass effect, and interindividual variability in gut microbial transformations. To overcome these drawbacks, various strategies for oral administration including solid dispersions, micro-nanoparticles, inclusion complexes, self- emulsifying systems, polymorphs have been proposed. Here, we have listed an updated description of pursued micro/nanotechnological approaches focusing on the fabrication processes and the features of the obtained products, as well as on the positive results yielded by in vitro and in vivo studies in comparison to the raw material.
  • Ellagitannins in Cancer Chemoprevention and Therapy

    Ellagitannins in Cancer Chemoprevention and Therapy

    toxins Review Ellagitannins in Cancer Chemoprevention and Therapy Tariq Ismail 1, Cinzia Calcabrini 2,3, Anna Rita Diaz 2, Carmela Fimognari 3, Eleonora Turrini 3, Elena Catanzaro 3, Saeed Akhtar 1 and Piero Sestili 2,* 1 Institute of Food Science & Nutrition, Faculty of Agricultural Sciences and Technology, Bahauddin Zakariya University, Bosan Road, Multan 60800, Punjab, Pakistan; [email protected] (T.I.); [email protected] (S.A.) 2 Department of Biomolecular Sciences, University of Urbino Carlo Bo, Via I Maggetti 26, 61029 Urbino (PU), Italy; [email protected] 3 Department for Life Quality Studies, Alma Mater Studiorum-University of Bologna, Corso d'Augusto 237, 47921 Rimini (RN), Italy; [email protected] (C.C.); carmela.fi[email protected] (C.F.); [email protected] (E.T.); [email protected] (E.C.) * Correspondence: [email protected]; Tel.: +39-(0)-722-303-414 Academic Editor: Jia-You Fang Received: 31 March 2016; Accepted: 9 May 2016; Published: 13 May 2016 Abstract: It is universally accepted that diets rich in fruit and vegetables lead to reduction in the risk of common forms of cancer and are useful in cancer prevention. Indeed edible vegetables and fruits contain a wide variety of phytochemicals with proven antioxidant, anti-carcinogenic, and chemopreventive activity; moreover, some of these phytochemicals also display direct antiproliferative activity towards tumor cells, with the additional advantage of high tolerability and low toxicity. The most important dietary phytochemicals are isothiocyanates, ellagitannins (ET), polyphenols, indoles, flavonoids, retinoids, tocopherols. Among this very wide panel of compounds, ET represent an important class of phytochemicals which are being increasingly investigated for their chemopreventive and anticancer activities.
  • Inhibitory Effect of Tannins from Galls of Carpinus Tschonoskii on the Degranulation of RBL-2H3 Cells

    Inhibitory Effect of Tannins from Galls of Carpinus Tschonoskii on the Degranulation of RBL-2H3 Cells

    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Tsukuba Repository Inhibitory effect of tannins from galls of Carpinus tschonoskii on the degranulation of RBL-2H3 Cells 著者 Yamada Parida, Ono Takako, Shigemori Hideyuki, Han Junkyu, Isoda Hiroko journal or Cytotechnology publication title volume 64 number 3 page range 349-356 year 2012-05 権利 (C) Springer Science+Business Media B.V. 2012 The original publication is available at www.springerlink.com URL http://hdl.handle.net/2241/117707 doi: 10.1007/s10616-012-9457-y Manuscript Click here to download Manuscript: antiallergic effect of Tannin for CT 20111215 revision for reviewerClick here2.doc to view linked References Parida Yamada･Takako Ono･Hideyuki Shigemori･Junkyu Han･Hiroko Isoda Inhibitory Effect of Tannins from Galls of Carpinus tschonoskii on the Degranulation of RBL-2H3 Cells Parida Yamada･Junkyu Han･Hiroko Isoda (✉) Alliance for Research on North Africa, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki 305-8572, Japan Takako Ono･Hideyuki Shigemori･Junkyu Han･Hiroko Isoda Graduate School of Life and Environmental Sciences, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki 305-8572, Japan Corresponding author Hiroko ISODA, Professor, Ph.D. University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki 305-8572, Japan Tel: +81 29-853-5775, Fax: +81 29-853-5776. E-mail: [email protected] 1 Abstract In this study, the anti-allergy potency of thirteen tannins isolated from the galls on buds of Carpinus tschonoskii (including two tannin derivatives) was investigated. RBL-2H3 (rat basophilic leukemia) cells were incubated with these compounds, and the release of β-hexosaminidase and cytotoxicity were measured.
  • The Metabolomic-Gut-Clinical Axis of Mankai Plant-Derived Dietary Polyphenols

    The Metabolomic-Gut-Clinical Axis of Mankai Plant-Derived Dietary Polyphenols

    nutrients Article The Metabolomic-Gut-Clinical Axis of Mankai Plant-Derived Dietary Polyphenols Anat Yaskolka Meir 1 , Kieran Tuohy 2, Martin von Bergen 3, Rosa Krajmalnik-Brown 4, Uwe Heinig 5, Hila Zelicha 1, Gal Tsaban 1 , Ehud Rinott 1, Alon Kaplan 1, Asaph Aharoni 5, Lydia Zeibich 6, Debbie Chang 6, Blake Dirks 6, Camilla Diotallevi 2,7, Panagiotis Arapitsas 2 , Urska Vrhovsek 2, Uta Ceglarek 8, Sven-Bastiaan Haange 3 , Ulrike Rolle-Kampczyk 3 , Beatrice Engelmann 3, Miri Lapidot 9, Monica Colt 9, Qi Sun 10,11,12 and Iris Shai 1,10,* 1 Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva 8410501, Israel; [email protected] (A.Y.M.); [email protected] (H.Z.); [email protected] (G.T.); [email protected] (E.R.); [email protected] (A.K.) 2 Department of Food Quality and Nutrition, Fondazione Edmund Mach, Research and Innovation Centre, Via E. Mach, 1, San Michele all’Adige, 38098 Trento, Italy; [email protected] (K.T.); [email protected] (C.D.); [email protected] (P.A.); [email protected] (U.V.) 3 Department of Molecular Systems Biology, Helmholtz Centre for Environmental Research GmbH, 04318 Leipzig, Germany; [email protected] (M.v.B.); [email protected] (S.-B.H.); [email protected] (U.R.-K.); [email protected] (B.E.) 4 Biodesign Center for Health through Microbiomes, School of Sustainable Engineering and the Built Environment, Arizona State University, Tempe, AZ 85281, USA; [email protected] 5 Department of Plant and Environmental Sciences,
  • Identification of Novel Urolithin Metabolites in Human Feces And

    Identification of Novel Urolithin Metabolites in Human Feces And

    This is an open access article published under an ACS AuthorChoice License, which permits copying and redistribution of the article or any adaptations for non-commercial purposes. Article Cite This: J. Agric. Food Chem. 2019, 67, 11099−11107 pubs.acs.org/JAFC Identification of Novel Urolithin Metabolites in Human Feces and Urine after the Intake of a Pomegranate Extract Rocío García-Villalba, María V. Selma, Juan C. Espín, and Francisco A. Tomas-Barberá ń* Laboratory of Food & Health, Research Group on Quality, Safety, and Bioactivity of Plant Foods, Department of Food Science and Technology, CEBAS-CSIC, P.O. Box 164, Campus de Espinardo, Murcia 30100, Spain *S Supporting Information ABSTRACT: Urolithins are bioactive gut microbiota metabolites of ellagic acid. Here, we have identified four unknown urolithins in human feces after the intake of a pomegranate extract. The new metabolites occurred only in 19% of the subjects. 4,8,9,10-Tetrahydroxy urolithin, (urolithin M6R), was unambiguously identified by 1H NMR, UV, and HRMS. Three metabolites were tentatively identified by the UV, HRMS, and chromatographic behavior, as 4,8,10-trihydroxy (urolithin M7R), 4,8,9-trihydroxy (urolithin CR), and 4,8-dihydroxy (urolithin AR) urolithins. Phase II conjugates of the novel urolithins were detected in urine and confirmed their absorption, circulation, and urinary excretion. The production of the new urolithins was not specific of any of the known urolithin metabotypes A and B. The new metabolites needed a bacterial 3-dehydroxylase activity for their production, and this is a novel feature as all the previously known urolithins maintained the hydroxyl at 3 position.
  • In Vivo Anti-Inflammatory and Antioxidant Properties of Ellagitannin

    In Vivo Anti-Inflammatory and Antioxidant Properties of Ellagitannin

    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Okayama University Scientific Achievement Repository 1 In vivo anti-inflammatory and antioxidant properties of ellagitannin 2 metabolite urolithin A 3 4 5 Hidekazu Ishimotoa, Mari Shibatab, Yuki Myojinc, Hideyuki Itoa,c,*, Yukio Sugimotob, 6 Akihiro Taid, and Tsutomu Hatanoa 7 8 a Department of Pharmacognosy, Division of Pharmaceutical Sciences, Okayama 9 University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 1-1-1 10 Tsushimanaka, Kita-ku, Okayama 700-8530, Japan 11 b Department of Pharmacology, Division of Pharmaceutical Sciences, Okayama 12 University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 1-1-1 13 Tsushimanaka, Kita-ku, Okayama 700-8530, Japan 14 c Department of Pharmacognosy, Faculty of Pharmaceutical Sciences, Okayama 15 University, 1-1-1 Tsushimanaka, Kita-ku, Okayama 700-8530, Japan 16 d Faculty of Life and Environmental Sciences, Prefectural University of Hiroshima, 562 17 Nanatsuka-cho, Shobara, Hiroshima 727-0023, Japan 18 19 20 *Corresponding Author 21 Phone & fax: +81 86 251 7937; e-mail: [email protected] 22 1 23 ABSTRACT 24 Urolithin A is a major metabolite produced by rats and humans after consumption of 25 pomegranate juice or pure ellagitannin geraniin. In this study, we investigated the 26 anti-inflammatory effect of urolithin A on carrageenan-induced paw edema in mice. The 27 volume of paw edema was reduced at 1 h after oral administration of urolithin A. In 28 addition, plasma in treated mice exhibited significant oxygen radical antioxidant 29 capacity (ORAC) scores with high plasma levels of the unconjugated form at 1 h after 30 oral administration of urolithin A.
  • Phase II Conjugates of Urolithins Isolated from Human Urine and Potential Role of B-Glucuronidases in Their Disposition S

    Phase II Conjugates of Urolithins Isolated from Human Urine and Potential Role of B-Glucuronidases in Their Disposition S

    Supplemental material to this article can be found at: http://dmd.aspetjournals.org/content/suppl/2017/03/10/dmd.117.075200.DC1 1521-009X/45/6/657–665$25.00 https://doi.org/10.1124/dmd.117.075200 DRUG METABOLISM AND DISPOSITION Drug Metab Dispos 45:657–665, June 2017 Copyright ª 2017 by The American Society for Pharmacology and Experimental Therapeutics Phase II Conjugates of Urolithins Isolated from Human Urine and Potential Role of b-Glucuronidases in Their Disposition s Jakub P. Piwowarski, Iwona Stanisławska, Sebastian Granica, Joanna Stefanska, and Anna K. Kiss Department of Pharmacognosy and Molecular Basis of Phytotherapy, Faculty of Pharmacy (J.P.P., I.S., S.G., A.K.K.), and Department of Pharmaceutical Microbiology, Centre for Preclinical Research and Technology (CePT) (J.S.), Medical University of Warsaw, Warsaw, Poland; Primary Laboratory of Origin: Medical University of Warsaw, Faculty of Pharmacy Received January 24, 2017; accepted March 1, 2017 ABSTRACT In recent years, many xenobiotics derived from natural products tissue, and urine. The aim of this study was to isolate and Downloaded from have been shown to undergo extensive metabolism by gut micro- structurally characterize urolithin conjugates from the urine of a biota. Ellagitannins, which are high molecular polyphenols, are volunteer who ingested ellagitannin-rich natural products, and to metabolized to dibenzo[b,d]pyran-6-one derivatives—urolithins. evaluate the potential role of b-glucuronidase–triggered cleavage These compounds, in contrast with their parental compounds, have in urolithin disposition. Glucuronides of urolithin A, iso-urolithin A, good bioavailability and are found in plasma and urine at micromo- and urolithin B were isolated and shown to be cleaved by the lar concentrations.